Palvella Therapeutics, Inc.

PVLA

Market cap$2.16 B

Rank#2076

Filings772

Palvella Therapeutics, Inc. has filed 772 public company documents between 2013 and 2026. The most frequent type is major company event (208 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchPVLA overview$2.16 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #2076See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut PVLA beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow PVLA via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
D	D	11y ago2014-12-31	-	View filing
D	D	11y ago2014-12-31	-	View filing
8-K	Major company event	11y ago2014-12-23	2014-12-17	View filing
8-K	Major company event	11y ago2014-12-18	2014-12-17	View filing
10-Q/A	Quarterly report (amended)	11y ago2014-12-12	2014-09-30	View filing
8-K	Major company event	11y ago2014-12-05	2014-12-05	View filing
10-Q	Quarterly report	11y ago2014-11-13	2014-09-30	View filing
10-K	Annual report	11y ago2014-09-12	2014-06-30	View filing
10-Q	Quarterly report	12y ago2014-06-02	2014-03-31	View filing
10-Q	Quarterly report	12y ago2014-05-14	2013-12-31	View filing
EFFECT	EFFECT	12y ago2014-01-28	-	View filing
CORRESP	Company correspondence	12y ago2014-01-24	-	View filing
S-1/A	S-1/A	12y ago2014-01-13	-	View filing
UPLOAD	SEC correspondence	12y ago2014-01-06	-	View filing

Palvella Therapeutics, Inc.

Similar companies to research next

Year